Bile acid signaling in metabolic disease and drug therapy

Cites (435)

Items 201–400 of 435

1. Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice
   Takaharu Maruyama, Kenichi Tanaka, Jun Suzuki, Hiroyuki Miyoshi, Naomoto Harada, Takao Nakamura, Yasuhisa Miyamoto, Akio Kanatani, Yoshitaka Tamai · 2006 · Journal of Endocrinology
2. Liver-specific Activities of FGF19 Require Klotho beta
   Benjamin C. Lin, Manping Wang, C. A. Blackmore, Luc Desnoyers · 2007 · Journal of Biological Chemistry
3. ChREBP, a Transcriptional Regulator of Glucose and Lipid Metabolism
   Catherine Postic, Renaud Dentin, Pierre‐Damien Denechaud, Jean R Girard · 2007 · Annual Review of Nutrition
4. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element
   Thierry Claudel, Ekkehard Sturm, Hélène Duez, Inès Pineda‐Torra, Audrey Sirvent, Vladimir Kosykh, Jean‐Charles Fruchart, Jean Dallongeville, Dean W. Hum, Folkert Kuipers et al. · 2002 · Journal of Clinical Investigation
5. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis #
   Frank G. Schaap, Niels Anthony Van Der Gaag, Dirk Jan Gouma, Peter L. M. Jansen · 2008 · Hepatology
6. Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
   Galya Vassileva, Andrei Golovko, Lisa Markowitz, Susan J. Abbondanzo, Ming Zeng, Shijun Yang, Lizbeth M. Hoos, Glen G. Tetzloff, Diane J. Levitan, Nicholas Murgolo et al. · 2006 · Biochemical Journal
7. The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain
   Keitel, Verena, Görg, Boris, Bidmon, Hans J., Zemtsova, Irina, Spomer, Lina, Zilles, Karl, Häussinger, Dieter · 2010 · Glia
8. The Orphan Nuclear Receptor Rev-erbα Recruits the N-CoR/Histone Deacetylase 3 Corepressor to Regulate the Circadian Bmal1 Gene
   Lei Yin, Mitchell A. Lazar · 2005 · Molecular Endocrinology
9. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy
   Christiane Pauli‐Magnus, Thomas Lang, Yvonne Meier, Tina Zodan-Marin, Diana Jung, Christian Breymann, Roland Zimmermann, Silke Kenngott, Ulrich H. Beuers, Christoph Reichel et al. · 2004 · Pharmacogenetics
10. New molecular insights into the mechanisms of cholestasis.
    Martin Wagner, G. Zollner, M. Trauner · 2009 · Journal of Hepatology
11. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression
    Thierry Claudel, Yusuke Inoue, Olivier Barbier, Daniel Durán-Sandoval, Vladimir Kosykh, Jamila Fruchart, Jean‐Charles Fruchart, Frank J. Gonzalez, Bart Staels · 2003 · Gastroenterology
12. The G Protein-Coupled Bile Acid Receptor, TGR5, Stimulates Gallbladder Filling
    Tingting Li, Sam R. Holmstrom, Serkan Kır, Michihisa Umetani, Daniel R. Schmidt, Steven A. Kliewer, David J. Mangelsdorf · 2011 · Molecular Endocrinology
13. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice
    Martin Wagner, Peter Fickert, Gernot Zollner, Andrea Fuchsbichler, Dagmar Silbert, Oleksiy Tsybrovskyy, Kurt Zatloukal, Grace Liejun Guo, John D. Schuetz, Frank J. Gonzalez et al. · 2003 · Gastroenterology
14. Discovery of 6α-Ethyl-23( S )-methylcholic Acid ( S -EMCA, INT-777) as a Potent and Selective Agonist for the TGR5 Receptor, a Novel Target for Diabesity
    Roberto Pellicciari, Antimo Gioiello, Antonio Macchiarulo, Charles Thomas, Emiliano Rosatelli, Benedetto Natalini, Roccaldo Sardella, Mark Pruzanski, Aldo Roda, Elisabetta Pastorini et al. · 2009 · Journal of Medicinal Chemistry
15. Nuclear Receptors in Liver Disease Δ
    Wagner, Martin, Zollner, Gernot, Trauner, Michael · 2011 · Hepatology
16. Farnesoid X receptor targeting to treat nonalcoholic steatohepatitis
    Adorini, Luciano, Pruzanski, Mark, Shapiro, David · 2012 · Drug Discovery Today
17. Glucose Regulates the Expression of the Farnesoid X Receptor in Liver
    Daniel Durán-Sandoval, Gisèle Mautino, Geneviève Martin, Frédéric Percevault, Olivier Barbier, Jean‐Charles Fruchart, Folkert Kuipers, Bart Staels · 2004 · Diabetes
18. MicroRNAs in Metabolic Disease
    Fernández-Hernando, Carlos, Ramírez, Cristina M., Goedeke, Leigh, Suárez, Yajaira · 2013 · Arteriosclerosis, Thrombosis, and Vascular Biology
19. Functional Variants of the Central Bile Acid Sensor FXR Identified in Intrahepatic Cholestasis of Pregnancy
    Saskia W. C. van Mil, Alexandra Milona, Peter H. Dixon, Roman Müllenbach, Victoria L. Geenes, Jenny Chambers, Vasylyna Shevchuk, Gudrun E. Moore, Frank Lammert, Anna Glantz et al. · 2007 · Gastroenterology
20. Influence of the HDL Receptor SR-BI on Lipoprotein Metabolism and Atherosclerosis
    Bernardo L. Trigatti, Monty Krieger, Attilio Rigotti · 2003 · Arteriosclerosis Thrombosis and Vascular Biology
21. Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure
    光博 渡辺, Yasushi Horai, Sander M. Houten, Kohkichi Morimoto, Taichi Sugizaki, Eri Arita, Chikage Mataki, Hiroyuki Sato, Yusuke Tanigawara, Kristina Schoonjans et al. · 2011 · Journal of Biological Chemistry
22. Liver Receptor Homologue-1 Mediates Species- and Cell Line-specific Bile Acid-dependent Negative Feedback Regulation of the Apical Sodium-dependent Bile Acid Transporter
    Frank Chen, Lin Ma, Paul A. Dawson, Christopher J. Sinal, Ephraim Sehayek, Frank J. Gonzalez, Jan L. Breslow, Meenakshisundaram Ananthanarayanan, Benjamin L. Shneider · 2003 · Journal of Biological Chemistry
23. A Novel Constitutive Androstane Receptor-Mediated and CYP3A-Independent Pathway of Bile Acid Detoxification
    Simrat P. S. Saini, Junichiro Sonoda, Li Xu, David Toma, Hirdesh Uppal, Ying Mu, Songrong Ren, David D. Moore, Ronald M. Evans, Wen Xie · 2004 · Molecular Pharmacology
24. Gut microbiota and non-alcoholic fatty liver disease: new insights
    Judith Aron‐Wisnewsky, Bénédicte Gaborit, Anne Dutour, Karine Clément · 2013 · Clinical Microbiology and Infection
25. Transgenic expression of cholesterol 7α‐hydroxylase in the liver prevents high‐fat diet–induced obesity and insulin resistance in mice†
    Tiangang Li, Erika Owsley, Michelle Matozel, Peter Hsu, Colleen M. Novak, John Y.L. Chiang · 2010 · Hepatology
26. Expression and activation of the farnesoid X receptor in the vasculature
    David Bishop‐Bailey, Desmond T. Walsh, Timothy David Warner · 2004 · Proceedings of the National Academy of Sciences
27. The Farnesoid X Receptor Modulates Hepatic Carbohydrate Metabolism during the Fasting-Refeeding Transition
    Daniel Durán-Sandoval, Bertrand Cariou, Frédéric Percevault, Nathalie Hennuyer, Aldo Grefhorst, Theo H. van Dijk, Frank J. Gonzalez, Jean‐Charles Fruchart, Folkert Kuipers, Bart Staels · 2005 · Journal of Biological Chemistry
28. Identification of a sister gene to P-glycoprotein.
    Sarah J. Childs, R L Yeh, Eijas Georges, Victor Wei Teik Ling · 1995 · PubMed
29. Microrna-27b Is a Regulatory Hub in Lipid Metabolism and Is Altered in Dyslipidemia
    Kasey C. Vickers, Bassem M. Shoucri, Michael G. Levin, Han Wu, Daniel S. Pearson, David O. Osei-Hwedieh, Francis S. Collins, Alan Thomas Remaley, Praveen Sethupathy · 2012 · Hepatology
30. The Constitutive Androstane Receptor Is an Anti-obesity Nuclear Receptor That Improves Insulin Sensitivity
    Jie Gao, Jinhan He, Yonggong Zhai, Taira Wada, Wen Xie · 2009 · Journal of Biological Chemistry
31. Bile acid-induced negative feedback regulation of the human ileal bile acid transporter
    Ezequiel Neimark, Frank Chen, Xiaoping Li, Benjamin L. Shneider · 2004 · Hepatology
32. Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor
    Steven A. Kliewer, Timothy Mark Willson · 2002 · Journal of Lipid Research
33. Expression of ABCG5 and ABCG8 Is Required for Regulation of Biliary Cholesterol Secretion
    Liqing Yu, Sarita S. Gupta, Fang Xu, Amy D. B. Liverman, Antonio Moschetta, David J. Mangelsdorf, Joyce J. Repa, Helen H. Hobbs, Jonathan C. Cohen · 2004 · Journal of Biological Chemistry
34. TGR 5 signalling inhibits the production of pro‐inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease
    Kazuaki Yoneno∥, Tadakazu Hisamatsu, Katsuyoshi Shimamura, Nobuhiko Kamada, Riko Ichikawa, Mina T. Kitazume, Maiko Mori, Michihide Uo, Yuka Namikawa, Katsuyoshi Matsuoka et al. · 2013 · Immunology
35. Ligand-activated Pregnane X Receptor Interferes with HNF-4 Signaling by Targeting a Common Coactivator PGC-1α
    Sonali Bhalla, Veli Cengiz Özalp, Sungsoon Fang, Lingjin Xiang, Jongsook Kim Kemper · 2004 · Journal of Biological Chemistry
36. Metabolic Syndrome: Focus on Dyslipidemia
    Henry N. Ginsberg, Yuanli Zhang, Antonio Hernández‐Ono · 2006 · Obesity
37. Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury
    Catherine A. M. Stedman, Christopher Liddle, Sally Coulter, Junichiro Sonoda, Jacqueline G. A. Alvarez, David D. Moore, Ronald M. Evans, Michael Downes · 2005 · Proceedings of the National Academy of Sciences
38. The organic solute transporter α-β, Ostα-Ostβ, is essential for intestinal bile acid transport and homeostasis
    Anuradha Rao, Jamie Haywood, Ann L. Craddock, Martin G. Belinsky, Gary D. Kruh, Paul A. Dawson · 2008 · Proceedings of the National Academy of Sciences
39. Overexpression of Cholesterol 7α-Hydroxylase Promotes Hepatic Bile Acid Synthesis and Secretion and Maintains Cholesterol Homeostasis Δ
    Tiangang Li, Michelle Matozel, Shannon Boehme, Bo Kong, Lisa-Mari Nilsson, Grace Liejun Guo, Ewa C. S. Ellis, John Y.L. Chiang · 2010 · Hepatology
40. Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
    McMahan, Rachel H., Wang, Xiaoxin X., Cheng, Lin Ling, Krisko, Tibor, Smith, Maxwell, El Kasmi, Karim, Pruzanski, Mark, Adorini, Luciano, Golden-Mason, Lucy, Levi, Moshe et al. · 2013 · Journal of Biological Chemistry
41. Bile Acid Synthesis in Humans Has a Rapid Diurnal Variation That Is Asynchronous With Cholesterol Synthesis
    Cecilia Gälman, Bo Angelin, Mats J. Rudling · 2005 · Gastroenterology
42. Scavenger Receptor Class B Type I–Mediated Protection Against Atherosclerosis in LDL Receptor–Negative Mice Involves Its Expression in Bone Marrow–Derived Cells
    Scott D. Covey, Monty Krieger, Wei Wang, Marsha Penman, Bernardo L. Trigatti · 2003 · Arteriosclerosis Thrombosis and Vascular Biology
43. Enterohepatic Circulation of Bile Salts in Farnesoid X Receptor-deficient Mice
    Tineke Kok, Christian Victor Hulzebos, Henk Wolters, Rick Havinga, Luis B. Agellon, Frans Stellaard, Bei Shan, Margrit Schwarz, Folkert Kuipers · 2003 · Journal of Biological Chemistry
44. A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass
    Glenn S. Gerhard, Amanda M. Styer, G. Craig Wood, Stephen L. Roesch, Anthony T. Petrick, Jon D. Gabrielsen, William E. Strodel, Christopher D. Still, George A. Argyropoulos · 2013 · Diabetes Care
45. Control of Cholesterol Metabolism and Plasma High-Density Lipoprotein Levels by microRNA-144
    Ramírez, Cristina M., Rotllan, Noemi, Vlassov, Alexander V., Dávalos, Alberto, Li, Mu, Goedeke, Leigh, Aranda, Juan F., Cirera-Salinas, Daniel, Araldi, Elisa, Salerno, Alessandro et al. · 2013 · Circulation Research
46. Regulation of Bile Acid Synthesis by the Nuclear Receptor Rev-erbα
    Hélène Duez, Jelske N. van der Veen, Christian Duhem, Benoît Pourcet, Thierry Touvier, Coralie Fontaine, Bruno Derudas, Eric Baugé, Rick Havinga, Vincent W. Bloks et al. · 2008 · Gastroenterology
47. Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7α-hydroxylase gene transcription
    Tiangang Li, John Y.L. Chiang · 2004 · American Journal of Physiology-Gastrointestinal and Liver Physiology
48. Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With Metformin
    Harold Edward Bays, Ronald B Goldberg, Kenneth E. Truitt, Michael R. Jones · 2008 · Archives of Internal Medicine
49. Glucose and Insulin Induction of Bile Acid Synthesis
    Tiangang Li, Jessica M. Ferrell, Shannon Boehme, Adrian Ochoa, Youcai Zhang, Curtis D. Klaassen, Sandra K. Erickson, John Y.L. Chiang · 2011 · Journal of Biological Chemistry
50. Expression of the liver-enriched transcriptional activator protein DBP follows a stringent circadian rhythm
    Jérôme Wuarin, Ueli Schibler · 1990 · Cell
51. Regulation of Bile Acid Synthesis by Fat-soluble Vitamins A and D
    Daniel R. Schmidt, Sam R. Holmstrom, Klementina Fon Tacer, Angie L. Bookout, Steven A. Kliewer, David J. Mangelsdorf · 2010 · Journal of Biological Chemistry
52. Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
    Sushant Bhatnagar, Holly A. Damron, F. Bradley Hillgartner · 2009 · Journal of Biological Chemistry
53. Carbohydrate responsive element-binding protein (ChREBP): a key regulator of glucose metabolism and fat storage
    Kosaku Uyeda, Hiromi Yamashita, Takumi Kawaguchi · 2002 · Biochemical Pharmacology
54. Bile acid signaling in lipid metabolism: Metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice
    Yunpeng Qi, Changtao Jiang, Jie Cheng, Kristopher W. Krausz, Tiangang Li, Jessica M. Ferrell, Frank J. Gonzalez, John Y.L. Chiang · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
55. Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats.
    Raylene A. Reimer, Michael I. McBurney · 1996 · Endocrinology
56. Targeted Disruption of the Microsomal Epoxide Hydrolase Gene
    Masaaki Miyata, Gen Kudo, Ying‐Hue Lee · 1999 · Journal of Biological Chemistry
57. Improved Glycemic Control with Colesevelam Treatment in Patients with Type 2 Diabetes Is Not Directly Associated with Changes in Bile Acid Metabolism
    Gemma Brufau, Frans Stellaard, Kris B. Prado, Vincent W. Bloks, Elles Jonkers, Renze Boverhof, Folkert Kuipers, Elizabeth J. Murphy · 2010 · Hepatology
58. Antiatherosclerotic effect of farnesoid X receptor
    Andrea Mencarelli, Barbara Renga, Eleonora Distrutti, Stefano Fiorucci · 2008 · American Journal of Physiology-Heart and Circulatory Physiology
59. Functional Inhibitory Cross-talk between Constitutive Androstane Receptor and Hepatic Nuclear Factor-4 in Hepatic Lipid/Glucose Metabolism Is Mediated by Competition for Binding to the DR1 Motif and to the Common Coactivators, GRIP-1 and PGC-1α
    Ji Miao, Sungsoon Fang, Yangjin Bae, Jongsook Kim Kemper · 2006 · Journal of Biological Chemistry
60. Bile Acid Derivatives as Ligands of the Farnesoid X Receptor. Synthesis, Evaluation, and Structure−Activity Relationship of a Series of Body and Side Chain Modified Analogues of Chenodeoxycholic Acid
    Roberto Pellicciari, Gabriele Costantino, Emidio Camaioni, Bahman M. Sadeghpour, Antonio Entrena, Timothy Mark Willson, Stefano Fiorucci, Carlo Clerici, Antimo Gioiello · 2004 · Journal of Medicinal Chemistry
61. Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine
    Raffaella Maria Gadaleta, Bas Oldenburg, Ellen C.L. Willemsen, Maureen Spit, Stefania Murzilli, Lorena Salvatore, Leo W. J. Klomp, Peter Derk Siersema, Karel J. van Erpecum, Saskia W. C. van Mil · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
62. The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element
    Prieur, Xavier, Coste, Hervé, Rodríguez, Joan C. · 2003 · Journal of Biological Chemistry
63. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice
    Péan, Noémie, Doignon, Isabelle, Garcin, Isabelle, Besnard, Aurore, Julien, Boris, Liu, Bingkaï, Branchereau, Sophie, Spraul, Anne, Guettier, Catherine, Humbert, Lydie et al. · 2013 · Hepatology
64. The bile acid sensor FXR regulates insulin transcription and secretion
    Barbara Renga, Andrea Mencarelli, Piero Vavassori, Vincenzo Brancaleone, Stefano Fiorucci · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
65. Identification of a Locus for Progressive Familial Intrahepatic Cholestasis PFIC2on Chromosome 2q24
    Sandra S. Strautnieks, Amir F. Kagalwalla, M. Stuart Tanner, Alex S. Knisely, Laura N. Bull, Nelson B. Freimer, Samuel A. Kocoshis, R M Gardiner, Richard J. Thompson · 1997 · The American Journal of Human Genetics
66. Gene expression profiling reveals a regulatory role for RORα and RORγ in phase I and phase II metabolism
    Hong Soon Kang, Martin Angers, Ju Youn Beak, Xiying Wu, Jeffrey M. Gimble, Taira Wada, Wen Xie, Jennifer B. Collins, Sherry F. Grissom, Anton M. Jetten · 2007 · Physiological Genomics
67. Diurnal Regulation of MTP and Plasma Triglyceride by CLOCK Is Mediated by SHP
    Xiaoyue Pan, Yuxia Zhang, Li Wang, M. Mahmood Hussain · 2010 · Cell Metabolism
68. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia.
    Bo Angelin, Kurt Einarsson, Kjell Hellström, Barbro Leijd · 1978 · Journal of Lipid Research
69. Loss of functional farnesoid X receptor increases atherosclerotic lesions in apolipoprotein E-deficient mice
    Elyisha A. Hanniman, Gilles C. Lambert, Tanya C. McCarthy, Christopher J. Sinal · 2005 · Journal of Lipid Research
70. FXR regulates organic solute transporters α and β in the adrenal gland, kidney, and intestine
    Hans Chulhee Lee, Yanqiao Zhang, Florence Y. Lee, Stanley F. Nelson, Frank J. Gonzalez, Peter A. Edwards · 2005 · Journal of Lipid Research
71. Circadian Expression Profiles of Drug-Processing Genes and Transcription Factors in Mouse Liver
    Yu-Kun Jennifer Zhang, Ronnie L. Yeager, Curtis D. Klaassen · 2008 · Drug Metabolism and Disposition
72. Nuclear receptors in bile acid metabolism
    Li, Tiangang, Chiang, John Y. L. · 2013 · Drug Metabolism Reviews
73. Farnesoid x receptor ligands inhibit vascular smooth muscle cell inflammation and migration
    Li, Yoyo T.Y., Swales, Karen E., Thomas, Gareth J., Warner, Timothy D., Bishop-Bailey, David · 2007 · Arteriosclerosis, Thrombosis, and Vascular Biology
74. Mir-33 regulates cell proliferation and cell cycle progression
    Daniel Cirera‐Salinas, Montse Pauta, Ryan M. Allen, Alessandro Gonzalez Salerno, Cristina M. Ramírez, Aránzazu Chamorro-Jorganes, Amarylis Claudine Bonito Azeredo Wanschel, Miguel Angel Lasunción, Manuel Morales‐Ruiz, Yajaira Suárez et al. · 2012 · Cell Cycle
75. Role of Multidrug Resistance 3 Deficiency in Pediatric and Adult Liver Disease: One Gene for Three Diseases
    Emmanuel Jacquemin · 2001 · Seminars in Liver Disease
76. FXR Deficiency Causes Reduced Atherosclerosis inLdlr−/−Mice
    Yanqiao Zhang, Xuping Wang, Charisse Vales, Florence Ying Lee, Hans Chulhee Lee, Aldons Jake Lusis, Peter A. Edwards · 2006 · Arteriosclerosis Thrombosis and Vascular Biology
77. Bile Acid Receptor TGR5 Agonism Induces NO Production and Reduces Monocyte Adhesion in Vascular Endothelial Cells
    Taiki Kida, Yoshiki Tsubosaka, Masatoshi Hori, Hiroshi Ozaki, Takahisa Murata · 2013 · Arteriosclerosis Thrombosis and Vascular Biology
78. Bile acids induce monocyte differentiation toward interleukin‐12 hypo‐producing dendritic cells via a TGR5‐dependent pathway
    Riko Ichikawa, Tetsuro Takayama, Kazuaki Yoneno∥, Nobuhiko Kamada, Mina T. Kitazume, Hajime Higuchi, Katsuyoshi Matsuoka, 光博 渡辺, Hiroshi Itoh, Takanori Kanai∥ et al. · 2012 · Immunology
79. Alterations in Lipid Metabolism Mediate Inflammation, Fibrosis, and Proliferation in a Mouse Model of Chronic Cholestatic Liver Injury
    Tarek Moustafa, Peter Fickert, Christoph Magnes, Christian Guelly, Andrea Thueringer, Saša Frank, Dagmar Kratky, Wolfgang Sattler, Helga Reicher, Frank Michael Sinner et al. · 2011 · Gastroenterology
80. Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study
    Carine Beysen, Elizabeth J. Murphy, K. Deines, Miram Chan, E. Tsang, Alexander Glass, Scott Turner, Joan Protasio, Timothy J. Riiff, M K Hellerstein · 2011 · Diabetologia
81. Activation of the Farnesoid X Receptor Induces Hepatic Expression and Secretion of Fibroblast Growth Factor 21
    Holly A. Cyphert, Xuemei Ge, Alison B. Kohan, Lisa M. Salati, Yanqiao Zhang, F. Bradley Hillgartner · 2012 · Journal of Biological Chemistry
82. Bile Acids Acutely Stimulate Insulin Secretion of Mouse β-Cells via Farnesoid X Receptor Activation and KATP Channel Inhibition
    Martina Düfer, Katrin Hörth, Rebecca Wagner, Björn Schittenhelm, Susanne Prowald, Thomas F.J. Wagner, Johannes Oberwinkler, Robert Łukowski, Frank J. Gonzalez, Peter Krippeit‐Drews et al. · 2012 · Diabetes
83. miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity
    Allen, Ryan M., Marquart, Tyler J., Albert, Carolyn J., Suchy, Frederick J., Wang, David Q.‐H., Ananthanarayanan, Meenakshisundaram, Ford, David A., Baldán, Ángel · 2012 · EMBO Molecular Medicine
84. Inborn Errors of Bile Acid Metabolism
    James E. Heubi, Kenneth D.R. Setchell, Kevin E. Bove · 2007 · Seminars in Liver Disease
85. Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene
    H. E. Wasmuth, Anna Glantz, Hildegard Keppeler · 2006 · Gut
86. ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy
    Roman Müllenbach, A Bennett, N Tetlow · 2005 · Gut
87. The Farnesoid X Receptor Promotes Adipocyte Differentiation and Regulates Adipose Cell Function in Vivo
    Giovanni Rizzo, Moises Di Sante, Andrea Mencarelli, Barbara Renga, Antimo Gioiello, Roberto Pellicciari, Stefano Fiorucci · 2006 · Molecular Pharmacology
88. Rat liver cholesterol 7 alpha-hydroxylase. Pretranslational regulation for circadian rhythm.
    M. Noshiro, M Nishimoto, K Okuda · 1990 · Journal of Biological Chemistry
89. The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance
    Tim C. M. A. Schreuder, Hendrik A. Marsman, Martin Leníček, Jochem R. van Werven, Aart Johannes Nederveen, Peter L. M. Jansen, Frank G. Schaap · 2010 · American Journal of Physiology-Gastrointestinal and Liver Physiology
90. Activation of farnesoid X receptor prevents atherosclerotic lesion formation in LDLR−/− and apoE−/− mice
    Helen B. Hartman, Stephen J. Gardell, Chris J. Petucci, Shuguang Wang, Julie A. Krueger, Mark J. Evans · 2009 · Journal of Lipid Research
91. Nuclear Hormone Receptors for Heme: REV-ERBα and REV-ERBβ Are Ligand-Regulated Components of the Mammalian Clock
    Thomas P. Burris · 2008 · Molecular Endocrinology
92. Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice
    Matthew J. Potthoff, Austin Potts, TianTeng He, João André Gonçalves Duarte, Ronald Taussig, David J. Mangelsdorf, Steven A. Kliewer, Shawn C. Burgess · 2012 · American Journal of Physiology-Gastrointestinal and Liver Physiology
93. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia
    Raymond Ng, Heng Wu, Hong Xiao, Xin Chen, Holger Willenbring, Clifford J. Steer, Guisheng Song · 2014 · Hepatology
94. MicroRNA 33 Regulates Glucose Metabolism
    Ramírez, Cristina M., Goedeke, Leigh, Rotllan, Noemi, Yoon, Je-Hyun, Cirera-Salinas, Daniel, Mattison, Julie A., Suárez, Yajaira, de Cabo, Rafael, Gorospe, Myriam, Fernández-Hernando, Carlos · 2013 · Molecular and Cellular Biology
95. Effects of Bariatric Surgery on Glucose Homeostasis and Type 2 Diabetes
    David P. Bradley, F. Magkos, S. Klein · 2012 · Gastroenterology
96. Regulation of cholesterol and bile acid homeostasis by the CYP7A1/SREBP2/miR-33a axis
    Tian-Gang Li, J. Francl, Shannon Boehme, John Y. L. Chiang · 2013 · Hepatology
97. The Role of MicroRNAs in Cholesterol Efflux and Hepatic Lipid Metabolism
    Kathryn J. Moore, Katey J. Rayner, Yajaira Suárez, Carlos F Fernandez-Hernando · 2011 · Annual Review of Nutrition
98. MicroRNAs Regulate Human Hepatocyte Nuclear Factor 4α, Modulating the Expression of Metabolic Enzymes and Cell Cycle
    Shingo Takagi, Miki Nakajima, Katsuhiko Kida, Yu Yamaura, Tatsuki Fukami, Tsuyoshi Yokoi · 2009 · Journal of Biological Chemistry
99. Farnesoid X Receptor Inhibits the Transcriptional Activity of Carbohydrate Response Element Binding Protein in Human Hepatocytes
    Sandrine Caron, Carolina Huaman Samanez, Hélène Dehondt, Maheul Ploton, Olivier Briand, Fleur Lien, Emilie Dorchies, Julie Dumont, Catherine Postic, Bertrand Cariou et al. · 2013 · Molecular and Cellular Biology
100. The human microbiome and bile acid metabolism: Dysbiosis, dysmetabolism, disease and intervention
     Jones, Mitchell L, Martoni, Christopher J, Ganopolsky, Jorge G, Labbé, Alain, Prakash, Satya · 2014 · Expert Opinion on Biological Therapy
101. microRNAs and cholesterol metabolism
     Kathryn J. Moore, Katey J. Rayner, Yajaira Suárez, Carlos F Fernandez-Hernando · 2010 · Trends in Endocrinology and Metabolism
102. Levels of 7α‐hydroxy‐4‐cholesten‐3‐one in plasma reflect rates of bile acid synthesis in man
     Magnus Axelson, Aly A, Jan Sjövall · 1988 · FEBS Letters
103. The gut microbiota and the metabolic health of the host
     Joyce, Susan A., Gahan, Cormac G.M. · 2014 · Current Opinion in Gastroenterology
104. Nuclear receptors as therapeutic targets in cholestatic liver diseases
     Zollner, Gernot, Trauner, Michael · 2009 · British Journal of Pharmacology
105. Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass
     Simonen, M., Dali-Youcef, N., Kaminska, D., Venesmaa, S., Käkelä, P., Pääkkönen, M., Hallikainen, M., Kolehmainen, M., Uusitupa, M., Moilanen, L. et al. · 2012 · Obesity Surgery
106. Circadian Dysregulation Disrupts Bile Acid Homeostasis
     Ke Ma, Rui Xiao, Hsiu-Ting Tseng, Lu Shan, Loning Fu, David D. Moore · 2009 · PLoS ONE
107. Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice
     Hongwei Wang, Madhukumar Venkatesh, Hao Li, Regina M. Goetz, Subhajit Mukherjee, Arunima Biswas, Liang Zhu, Andreas Kaubisch, Lei Wang, James M. Pullman et al. · 2011 · Journal of Clinical Investigation
108. Diurnal Regulation of Microsomal Triglyceride Transfer Protein and Plasma Lipid Levels
     Xiaoyue Pan, M. Mahmood Hussain · 2007 · Journal of Biological Chemistry
109. Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis
     Johannes Noé, Gerd Achim Kullak-Ublick, Wolfram Jochum, Bruno Stieger, Reinhold Kerb, Michael Haberl, Beat Müllhaupt, Peter J. Meier, Christiane Pauli‐Magnus · 2005 · Journal of Hepatology
110. The Human Gallbladder Secretes Fibroblast Growth Factor 19 Into Bile: Towards Defining the Role of Fibroblast Growth Factor 19 in the Enterobiliary Tract
     Serge J.L.B. Zweers, Klaske A. C. Booij, Mina Komuta, Tania Roskams, Dirk Jan Gouma, Peter L. M. Jansen, Frank G. Schaap · 2011 · Hepatology
111. Overexpression of Sphingosine Kinase 1 Prevents Ceramide Accumulation and Ameliorates Muscle Insulin Resistance in High-Fat Diet–Fed Mice
     Clinton R. Bruce, Steve Risis, Joanne R. Babb, Christine Yang, Greg M. Kowalski, Ahrathy Selathurai, Robert S. Lee, Jacquelyn M. Weir, Kazuaki Yoshioka, Yoh Takuwa et al. · 2012 · Diabetes
112. FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice
     Henning Wittenburg, Malcolm A. Lyons, Renhua Li, Gary A. Churchill, Martin C. Carey, Beverly J. Paigen · 2003 · Gastroenterology
113. A Novel Bile Acid-Activated Vitamin D Receptor Signaling in Human Hepatocytes
     Shuxin Han, Tiangang Li, Ewa C. S. Ellis, Stephen C. Strom, John Y.L. Chiang · 2010 · Molecular Endocrinology
114. Characterization of the Core Mammalian Clock Component, NPAS2, as a REV-ERBα/RORα Target Gene
     Christine Crumbley, Yongjun Wang, Douglas J. Kojetin, Thomas P. Burris · 2010 · Journal of Biological Chemistry
115. Molecular cloning, tissue distribution, and expression of a 14-kDa bile acid-binding protein from rat ileal cytosol.
     Yanhua Gong, Eric T. Everett, D A Schwartz, James Scott Norris, Frederick A. Wilson · 1994 · Proceedings of the National Academy of Sciences
116. Insulin, Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Insulin-Like Growth Factor I as Putative Mediators of the Hypolipidemic Effect of Oligofructose in Rats
     Nadine N. Kok, Linda Morgan, Christine M. Williams, Marcel B. Roberfroid, Jean‐Paul Thissen, Nathalie M. Delzenne · 1998 · Journal of Nutrition
117. Transintestinal cholesterol efflux
     Astrid E. van der Velde, Gemma Brufau, Albert Kornelis Groen · 2010 · Current Opinion in Lipidology
118. Effects of FXR in foam-cell formation and atherosclerosis development
     Grace Liejun Guo, Silvia Santamarina-Fojo, Taro E. Akiyama, Marcelo J. Amar, Beverly J. Paigen, Bryan Brewer, Frank J. Gonzalez · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
119. Compensatory Induction of Liver Efflux Transporters in Response to ANIT-Induced Liver Injury Is Impaired in FXR-Null Mice
     Yue Julia Cui, Lauren M. Aleksunes, Yuji Tanaka · 2009 · Toxicological Sciences
120. Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis
     Gernot Zollner, Martin Wagner, Peter Fickert, Dagmar Silbert, Judith Gumhold, Kurt Zatloukal, Helmut Denk, Michael A Trauner · 2007 · Liver International
121. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin–sensitive mechanism in murine and human hepatocytes†
     Paul Dent, Youwen Fang, Seema Gupta, Elaine J. Studer, Clint Mitchell, Sarah Spiegel, Philip B. Hylemon · 2005 · Hepatology
122. Regulation of cholesterol 7 alpha-hydroxylase in the liver. Purification of cholesterol 7 alpha-hydroxylase and the immunochemical evidence for the induction of cholesterol 7 alpha-hydroxylase by cholestyramine and circadian rhythm.
     Chiang, J Y, Miller, W F, Lin, G M · 1990 · Journal of Biological Chemistry
123. Diurnal Variations of Mouse Plasma and Hepatic Bile Acid Concentrations as well as Expression of Biosynthetic Enzymes and Transporters
     Yu-Kun Jennifer Zhang, Grace Liejun Guo, Curtis D. Klaassen · 2011 · PLoS ONE
124. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2)
     Verena Keitel, Anne T. Nies, Manuela Brom, Johanna Hummel-Eisenbeiss, Herbert Spring, Dietrich O. R. KEPPLER · 2003 · American Journal of Physiology-Gastrointestinal and Liver Physiology
125. The Role of FXR in Disorders of Bile Acid Homeostasis
     Jyrki J. Eloranta, Gerd Achim Kullak-Ublick · 2008 · Physiology
126. Sphingosine-1-phosphate receptor 2
     Mohamad M. Adada, Daniel Canals, Yusuf Awni Hannun, Lina Marie Obeid · 2013 · FEBS Journal
127. Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease
     Nijmeijer, Rian M., Gadaleta, Raffaella M., van Mil, Saskia W. C., van Bodegraven, Adriaan A., Crusius, J. Bart A., Dijkstra, Gerard, Hommes, Daan W., de Jong, Dirk J., Stokkers, Pieter C. F., Verspaget, Hein W. et al. · 2011 · PLoS ONE
128. A Role of the Bile Salt Receptor FXR in Atherosclerosis
     Jurre Hageman, Hilde Herrema, Albert Kornelis Groen, Folkert Kuipers · 2010 · Arteriosclerosis Thrombosis and Vascular Biology
129. Circadian Clock-Controlled Intestinal Expression of the Multidrug-Resistance Gene mdr1a in Mice
     Yûichi Murakami, Yuko Higashi, Naoya Matsunaga, Satoru Koyanagi, Shigehiro Ohdo · 2008 · Gastroenterology
130. Activation of PXR induces hypercholesterolemia in wild-type and accelerates atherosclerosis in apoE deficient mice
     Changcheng Zhou, Nakesha King, Kwan Y. Chen, Jan L. Breslow · 2009 · Journal of Lipid Research
131. Nuclear Receptors as New Perspective for the Management of Liver Diseases
     Michael Trauner, Emina Halilbasic · 2011 · Gastroenterology
132. Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes
     Cédric Langhi, Cédric Le May, Sanae Kourimate, Sandrine Caron, Bart Staels, Michel Krempf, Philippe Costet, Bertrand Cariou · 2008 · FEBS Letters
133. Identification of Novel Pathways That Control Farnesoid X Receptor-mediated Hypocholesterolemia
     Zhang, Yanqiao, Yin, Liya, Anderson, Jody, Ma, Huiyan, Gonzalez, Frank J., Willson, Timothy M., Edwards, Peter A. · 2010 · Journal of Biological Chemistry
134. Common genetic variations inCLOCKtranscription factor are associated with nonalcoholic fatty liver disease
     Silvia C. Sookoian · 2007 · World Journal of Gastroenterology
135. Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19
     Cecilia Gälman, Bo Angelin, Mats J. Rudling · 2011 · Journal of Internal Medicine
136. Intestinal Bile Acids and Cholesterol Absorption in the Germfree Rat
     B. S. J. Wöstmann · 1973 · Journal of Nutrition
137. Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1
     Quan Shang, Monica Saumoy, Jens Juul Holst, Gerald Salen, Guorong Xu · 2009 · American Journal of Physiology-Gastrointestinal and Liver Physiology
138. The farnesoid X receptor induces very low density lipoprotein receptor gene expression
     Audrey Sirvent, Thierry Claudel, Geneviève Martin, John Brozek, Vladimir Kosykh, Raphaël Darteil, Dean W. Hum, Jean‐Charles Fruchart, Bart Staels · 2004 · FEBS Letters
139. Anti-inflammatory and metabolic actions of FXR: Insights into molecular mechanisms
     Danielle A.A. Hollman, Alexandra Milona, Karel J. van Erpecum, Saskia W. C. van Mil · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
140. Mechanism of Vitamin D Receptor Inhibition of Cholesterol 7α-Hydroxylase Gene Transcription in Human Hepatocytes
     Shuxin Han, John Y.L. Chiang · 2008 · Drug Metabolism and Disposition
141. Identification of the xenosensors regulating human 5-aminolevulinate synthase
     Michael Podvinec, Christoph Handschin, Renate Looser, Urs Meyer · 2004 · Proceedings of the National Academy of Sciences
142. The role of circadian timing system on drug metabolism and detoxification
     Frédéric Gachon, Dmitri Firsov · 2010 · Expert Opinion on Drug Metabolism & Toxicology
143. The rat hepatic leukemia factor (HLF) gene encodes two transcriptional activators with distinct circadian rhythms, tissue distributions and target preferences.
     Eileen Falvey, Fabienne Fleury-Olela, Ueli Schibler · 1995 · The EMBO Journal
144. Nongenomic Actions of Bile Acids. Synthesis and Preliminary Characterization of 23- and 6,23-Alkyl-Substituted Bile Acid Derivatives as Selective Modulators for the G-Protein Coupled Receptor TGR5
     Roberto Pellicciari, Hiroyuki Sato, Antimo Gioiello, Gabriele Costantino, Antonio Macchiarulo, Bahman M. Sadeghpour, Gianluca Giorgi, Kristina Schoonjans, Johan H. Auwerx · 2007 · Journal of Medicinal Chemistry
145. The nuclear receptor FXR is expressed in pancreatic β‐cells and protects human islets from lipotoxicity
     Iuliana Ristea Popescu, Audrey Helleboid‐Chapman, Anthony Lucas, Brigitte Vandewalle, Julie Dumont, Emmanuel Bouchaert, Bruno Derudas, Julie A. Kerr-Conte, Sandrine Caron, François N. Pattou et al. · 2010 · FEBS Letters
146. Independent Repression of Bile Acid Synthesis and Activation of c-Jun N-terminal Kinase (JNK) by Activated Hepatocyte Fibroblast Growth Factor Receptor 4 (FGFR4) and Bile Acids
     Chundong Yu, Fen Wang, Chengliu Jin, Xinqiang Huang, Wallace L. McKeehan · 2005 · Journal of Biological Chemistry
147. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism
     Xiaoli Hu, Ylva Bonde, Gösta Eggertsen, Mats J. Rudling · 2013 · Journal of Internal Medicine
148. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice
     Johanna H. M. Stroeve, Gemma Brufau, Frans Stellaard, Frank J. Gonzalez, Bart Staels, Folkert Kuipers · 2010 · Laboratory Investigation
149. Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor.
     Phyllissa Schmiedlin‐Ren, Kenneth E. Thummel, Jeannine M. Fisher · 2001 · PubMed
150. Genetic Variability, Haplotype Structures, and Ethnic Diversity of Hepatic Transporters MDR3 (ABCB4) and Bile Salt Export Pump (ABCB11)
     Thomas Lang, Michael Haberl, Diana Jung, Anja Drescher, Robert Schlagenhaufer, Andrea Keil, Esther Mornhinweg, Bruno Stieger, Gerd Achim Kullak-Ublick, Reinhold Kerb · 2006 · Drug Metabolism and Disposition
151. Multiple Mechanisms Regulate Circadian Expression of the Gene for Cholesterol 7α-Hydroxylase (Cyp7a) , a Key Enzyme in Hepatic Bile Acid Biosynthesis
     Mitsuhide Noshiro, Emiko Usui, Takeshi Kawamoto, Hiroshi Kubo, Katsumi Fujimoto, Masae Furukawa, Sato Honma, Makoto Makishima, Ken‐ichi Honma, Yukio Kato · 2007 · Journal of Biological Rhythms
152. Circadian Regulation of the Hepatic Endobiotic and Xenobitoic Detoxification Pathways: The Time Matters
     Uršula Prosenc Zmrzljak, Damjana Rozman · 2012 · Chemical Research in Toxicology
153. MicroRNAs
     Jennifer Sacco, Khosrow Adeli · 2012 · Current Opinion in Lipidology
154. Obesity and NAFLD
     Ajay Kumar. Duseja, Yogesh Kumar Chawla · 2013 · Clinics in Liver Disease
155. Noncoding RNAs and Atherosclerosis
     Binod Kumar Aryal, Noemí Rotllán, Carlos F Fernandez-Hernando · 2014 · Current Atherosclerosis Reports
156. Reverse Cholesterol Transport Revisited
     Gemma Brufau, Albert Kornelis Groen, Folkert Kuipers · 2011 · Arteriosclerosis Thrombosis and Vascular Biology
157. Deficiency of PXR decreases atherosclerosis in apoE-deficient mice
     Yipeng Sui, Jinxian Xu, Jennifer Rios-Pilier, Changcheng Zhou · 2011 · Journal of Lipid Research
158. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia
     Mark J. Evans, Paige E. Mahaney, Lisa Borges-Marcucci, KehDih Lai, Shuguang Wang, Julie A. Krueger, Stephen J. Gardell, Christine Huard, Robert Martinez, George P. Vlasuk et al. · 2009 · American Journal of Physiology-Gastrointestinal and Liver Physiology
159. Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy
     Jodie N. Painter, Miia Savander, Anne Ropponen · 2005 · European Journal of Human Genetics
160. Deoxycholic Acid Activates the c-Jun N-terminal Kinase Pathway via FAS Receptor Activation in Primary Hepatocytes
     Seema Gupta, Ramesh Natarajan, Shawn G. Payne, Elaine J. Studer, Sarah Spiegel, Paul Dent, Phillip B. Hylemon · 2004 · Journal of Biological Chemistry
161. Vitamin D Receptor-dependent Regulation of Colon Multidrug Resistance-associated Protein 3 Gene Expression by Bile Acids
     Tanya C. McCarthy, Xiufeng Li, Christopher J. Sinal · 2005 · Journal of Biological Chemistry
162. Chronic Ethanol Consumption Disrupts the Core Molecular Clock and Diurnal Rhythms of Metabolic Genes in the Liver without Affecting the Suprachiasmatic Nucleus
     Ashley N. Filiano, Telisha Millender-Swain, Russell Johnson, Martin Elliot Young, Karen L. Gamble, Shannon M. Bailey · 2013 · PLoS ONE
163. Analysis of bile acids in conventional and germfree rats
     David C. Madsen, M Beaver, L Chang, Edith Bruckner-Kardoss, B. S. J. Wöstmann · 1976 · Journal of Lipid Research
164. Vitamin D Receptor Regulation of the Steroid/Bile Acid Sulfotransferase SULT2A1
     Bandana Chatterjee, Ibtissam Echchgadda, Chung Seog Song · 2005 · Methods in enzymology on CD-ROM/Methods in enzymology
165. The Functional Expression of Sodium-dependent Bile Acid Transport in Madin-Darby Canine Kidney Cells Transfected with the cDNA for Microsomal Epoxide Hydrolase
     Patricia von Dippe, Mehran Amoui, Robert H. Stellwagen · 1996 · Journal of Biological Chemistry
166. The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders
     Vanesa Stepanov, Karmen Stankov, Momir Mikov · 2013 · Journal of Receptors and Signal Transduction
167. Diurnal Rhythmicity in the Transcription of Jejunal Drug Transporters
     Adam T. Stearns, Anita Balakrishnan, David B. Rhoads, Stanley W. Ashley, Ali Tavakkolizadeh · 2008 · Journal of Pharmacological Sciences
168. Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice
     Galya Vassileva, Weiwen Hu, Lizbeth M. Hoos, Glen G. Tetzloff, Shijun Yang, Li Liu, Ling Kang, Harry R. Davis, Joseph A. Hedrick, Lan Hong et al. · 2010 · Journal of Endocrinology
169. Vitamin D3 Modulates the Expression of Bile Acid Regulatory Genes and Represses Inflammation in Bile Duct-Ligated Mice
     Michitaka Ogura, Shigeru Nishida, Michiyasu Ishizawa, Kenichi Sakurai, Makoto Shimizu, Sadanori Matsuo, Sadao Amano, Shigeyuki Uno, Makoto Makishima · 2008 · Journal of Pharmacology and Experimental Therapeutics
170. Identification of the hepatocyte Na+-dependent bile acid transport protein using monoclonal antibodies.
     Meenakshisundaram Ananthanarayanan, Patricia von Dippe, D Levy · 1988 · Journal of Biological Chemistry
171. A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents
     Małgorzata Wójcik, Dominika Januś, Katarzyna Doleżal-Ołtarzewska, Anna Kalicka-Kasperczyk, Karolina Popławska, Dorota Drożdż, Krystyna Sztefko, Jerzy Starzyk · 2012 · Journal of Pediatric Endocrinology and Metabolism
172. Highly sensitive quantification of 7α-hydroxy-4-cholesten-3-one in human serum by LC-ESI-MS/MS
     Akira Honda, Kouwa Yamashita, Mitsuteru Numazawa, Tadashi Ikegami, Mikio Doy, Yasushi Matsuzaki, Hiroshi Miyazaki · 2006 · Journal of Lipid Research
173. Mouse Organic Solute Transporter α Deficiency Enhances Renal Excretion of Bile Acids and Attenuates Cholestasis
     Carol J. Soroka, Albert Mennone, Lee R. Hagey, Nazzareno Ballatori, James Lorenzen Boyer · 2009 · Hepatology
174. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8
     Laura Calpe‐Berdiel, Noemí Rotllán, Catherine Fiévet, Rosa Roig, Francisco Blanco‐Vaca, Joan Carles Escolá‐Gil · 2008 · Journal of Lipid Research
175. Transactivation of Rat Apical Sodium-Dependent Bile Acid Transporter and Increased Bile Acid Transport by 1α,25-Dihydroxyvitamin D3 via the Vitamin D Receptor
     Xianghai Chen, Frank Chen, Shanjun Liu, Hartmut Glaeser, Paul A. Dawson, Alan F. Hofmann, Richard B. Kim, Benjamin L. Shneider, K. Sandy Pang · 2006 · Molecular Pharmacology
176. The Impact of Farnesoid X Receptor Activation on Intestinal Permeability in Inflammatory Bowel Disease
     Maja Stojančević, Karmen Stankov, Momir Mikov · 2012 · Canadian Journal of Gastroenterology
177. Fibroblast Growth Factor 19 Treatment Ameliorates Disruption of Hepatic Lipid Metabolism in Farnesoid X Receptor (Fxr)-Null Mice
     Miyata, Masaaki, Sakaida, Yumi, Matsuzawa, Hitomi, Yoshinari, Kouichi, Yamazoe, Yasushi · 2011 · Biological and Pharmaceutical Bulletin
178. A putative role of micro RNA in regulation of cholesterol 7α-hydroxylase expression in human hepatocytes
     Kwang‐Hoon Song, Tiangang Li, Erika Owsley, John Y.L. Chiang · 2010 · Journal of Lipid Research
179. Daily Rhythms of P‐glycoprotein Expression in Mice
     Hitoshi Ando, Hayato Yanagihara, Koichi Sugimoto, Yohei Hayashi, Shuichi Tsuruoka, Toshinari Takamura, Shuichi Kaneko, Akio Fujimura · 2005 · Chronobiology International
180. Regulation of bile acid synthesis in man. Presence of a diurnal rhythm.
     W C Duane, David G. Levitt, Susan M. Mueller, J C Behrens · 1983 · Journal of Clinical Investigation
181. Discovery of 3-Aryl-4-isoxazolecarboxamides as TGR5 Receptor Agonists
     Karen Anderson Evans, Brian Budzik, Sean A. Ross, David D. Wisnoski, Jian Jun Jin, Ralph A. Rivero, Mythily Vimal, George R. Szewczyk, Channa K. Jayawickreme, David L. Moncol et al. · 2009 · Journal of Medicinal Chemistry
182. Farnesoid X-Activated Receptor Induces Apolipoprotein C-II Transcription: a Molecular Mechanism Linking Plasma Triglyceride Levels to Bile Acids
     H. R. Kast · 2001 · Molecular Endocrinology
183. Constitutive Androstane Receptor-Mediated Changes in Bile Acid Composition Contributes to Hepatoprotection from Lithocholic Acid-Induced Liver Injury in Mice
     Beilke, Lisa D., Aleksunes, Lauren M., Holland, Ricky D., Besselsen, David G., Beger, Rick D., Klaassen, Curtis D., Cherrington, Nathan J. · 2009 · Drug Metabolism and Disposition
184. Administration of Ampicillin Elevates Hepatic Primary Bile Acid Synthesis through Suppression of Ileal Fibroblast Growth Factor 15 Expression
     Miyata, Masaaki, Takamatsu, Yuki, Kuribayashi, Hideaki, Yamazoe, Yasushi · 2009 · The Journal of Pharmacology and Experimental Therapeutics
185. Glucose Sensing O-GlcNAcylation Pathway Regulates the Nuclear Bile Acid Receptor Farnesoid X Receptor (FXR)
     Wahiba Berrabah, Pierrette Aumercier, Céline Gheeraert, Hélène Dehondt, Emmanuel Bouchaert, Jérémy Alexandre, Maheul Ploton, Claire Mazuy, Sandrine Caron, Anne Tailleux et al. · 2013 · Hepatology
186. Failure of intravenous infusion of taurocholate to down-regulate cholesterol 7α-hydroxylase in rats with biliary fistulas
     William M. Pandak, Douglas M. Heuman, Phillip B. Hylemon, John Y.L. Chiang, Z. Reno Vlahčevič · 1995 · Gastroenterology
187. The Role of Gastrointestinal Hormones in Hepatic Lipid Metabolism
     Jamie E. Mells, Frank A. Anania · 2013 · Seminars in Liver Disease
188. Cytochrome P450 and the Biological Clock in Mammals
     Oren Froy · 2009 · Current Drug Metabolism
189. Molecular Clocks in Pharmacology
     Erik S. Musiek, Garret A. FitzGerald · 2013 · Handbook of experimental pharmacology
190. Neither intestinal sequestration of bile acids nor common bile duct ligation modulate the expression and function of the rat ileal bile acid transporter
     Marco A. Arrese, Michael A Trauner, Robert J. Sacchiero, Michael W. Crossman, Benjamin L. Shneider · 1998 · Hepatology
191. Pruritus in Chronic Cholestatic Liver Disease
     Chalermrat Bunchorntavakul, K. Rajender Reddy · 2012 · Clinics in Liver Disease
192. Chronic Ethanol Intake Alters Circadian Phase Shifting and Free-Running Period in Mice
     Joseph A. Seggio, Michael C. Fixaris, Jeffrey D. Reed, Ryan Wellington Logan, Alan M. Rosenwasser · 2009 · Journal of Biological Rhythms
193. FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells
     Qiuhong Zhang, Fengtian He, Ramalinga Kuruba, Xiang Gao, Annette Scierka Wilson, Jiang Li, Timothy R. Billiar, Bruce R. Pitt, Wen Xie, Song Li · 2007 · Cardiovascular Research
194. Retinoic Acid-related Orphan Receptor α Regulates Diurnal Rhythm and Fasting Induction of Sterol 12α-Hydroxylase in Bile Acid Synthesis
     Preeti Pathak, Tiangang Li, John Y.L. Chiang · 2013 · Journal of Biological Chemistry
195. Rhythmic expression of DEC1 and DEC2 in peripheral tissues: DEC2 is a potent suppressor for hepatic cytochrome P450s opposing DBP
     Mitsuhide Noshiro, Takeshi Kawamoto, Masae Furukawa, Katsumi Fujimoto, Yuzo Yoshida, Eri Sasabe, Shinichi Tsutsumi, Taizo Hamada, Sato Honma, Ken‐ichi Honma et al. · 2004 · Genes to Cells
196. Dietary fiber modulates intestinal proglucagon messenger ribonucleic acid and postprandial secretion of glucagon-like peptide-1 and insulin in rats
     Raylene A. Reimer · 1996 · Endocrinology
197. Lithocholic acid induction of the FGF19 promoter in intestinal cells is mediated by PXR
     Wolfgang Wistuba · 2007 · World Journal of Gastroenterology
198. Synthesis and SAR of 2-aryl-3-aminomethylquinolines as agonists of the bile acid receptor TGR5
     Mark R. Herbert, Dana L. Siegel, Lena M. Staszewski, Charmagne S. Cayanan, Urmi Banerjee, Sangeeta Dhamija, Jennifer Anderson, Amy Fan, Li Wang, Peter J. Rix et al. · 2010 · Bioorganic & Medicinal Chemistry Letters
199. Farnesoid X receptor agonists in biliary tract disease
     Stefano Fiorucci, Franco Baldelli · 2009 · Current Opinion in Gastroenterology
200. Association of bile acid receptor TGR5 variation and transit in health and lower functional gastrointestinal disorders
     Michael Camilleri, María I. Vázquez‐Roque, Paula Carlson, Duane B. Burton, Banny S. Wong, Alan R. Zinsmeister · 2011 · Neurogastroenterology & Motility